A Pilot Trial of Maraviroc for Treatment of Subjects on Antiretroviral Therapy With Suboptimal CD4 T-Cell Count Recovery Despite Sustained Virologic Suppression.
Phase of Trial: Phase II
Latest Information Update: 14 Oct 2018
At a glance
- Drugs Maraviroc (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 23 Feb 2012 Actual patient number (34) added as reported by ClinicalTrials.gov.
- 23 Feb 2012 Actual initiation date changed from Sep 2009 to Jan 2009 as reported by ClinicalTrials.gov.